Tigecycline: Difference between revisions

From IDWiki
No edit summary
No edit summary
 
Line 1: Line 1:
== Background ==
+
==Background==
   
 
*Glycylcycline antibiotic
 
*Glycylcycline antibiotic
Line 8: Line 8:
 
*Does cover [[Acinetobacter]] and [[Stenotrophomonas]]
 
*Does cover [[Acinetobacter]] and [[Stenotrophomonas]]
   
=== Pharmacokinetics and Pharmacodynamics ===
+
===Pharmacokinetics and Pharmacodynamics===
   
* Rapidly concentrates in tissue, but poor concentration in urine and lung tissue
+
*Rapidly concentrates in tissue, but poor concentration in urine and lung tissue
   
== Dosing ==
+
==Dosing==
   
* High dosing may be useful in HAP/VAP with 100 mg IV q12h
+
*'''Intraabdominal infection:''' 100 mg IV load followed by 50 mg IV q12h
  +
*'''Pneumonia:''' 100 mg IV load followed by 50 mg IV q12h
  +
**High dosing may be useful in HAP/VAP with 100 mg IV q12h
  +
*'''Skin and soft tissue infection:''' 100 mg IV load followed by 50 mg IV q12h
   
== Safety ==
+
==Safety==
   
* Black box warning for increased all-cause mortality (4 vs 3%), likely driven by standard dosing tigecycline in VAP
+
*Black box warning for increased all-cause mortality (4 vs 3%), likely driven by standard dosing tigecycline in VAP
  +
*Commonly causes nausea, vomiting, and diarrhea
  +
*Also anemia, thrombocytopenia, hepatitis, jaundice, AKI
   
 
[[Category:Glycylcyclines]]
 
[[Category:Glycylcyclines]]

Latest revision as of 08:56, 26 April 2021

Background

  • Glycylcycline antibiotic

Spectrum of Activity

Pharmacokinetics and Pharmacodynamics

  • Rapidly concentrates in tissue, but poor concentration in urine and lung tissue

Dosing

  • Intraabdominal infection: 100 mg IV load followed by 50 mg IV q12h
  • Pneumonia: 100 mg IV load followed by 50 mg IV q12h
    • High dosing may be useful in HAP/VAP with 100 mg IV q12h
  • Skin and soft tissue infection: 100 mg IV load followed by 50 mg IV q12h

Safety

  • Black box warning for increased all-cause mortality (4 vs 3%), likely driven by standard dosing tigecycline in VAP
  • Commonly causes nausea, vomiting, and diarrhea
  • Also anemia, thrombocytopenia, hepatitis, jaundice, AKI